Color Hereditary Cancer Test
A multi-cancer genetic test evaluating key hereditary risks—including breast, ovarian, and colorectal cancers—to help guide diagnosis and prevention.
Accessed through the Ovarian Cancer Sponsored Testing Program•Sponsored by AstraZeneca, GSK, Merck, Genentech, Ovarian Cancer Research Alliance•Performed by Color Health
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
This AstraZeneca-sponsored program through OCRA offers no-cost hereditary cancer testing for patients at elevated risk for ovarian and gynecologic cancers, as well as related hereditary cancer syndromes including breast, uterine/endometrial, colorectal, and prostate cancers. Testing is performed by Color Health using an at-home saliva kit, and results include access to certified genetic counselors to support clinical decision-making and risk stratification. Ordering carries no prescribing or purchase obligation.
When to consider this test
Patient selection
- (Note: This program does not require an outside provider to initiate testing. Color’s clinical team handles authorization.)
- Providers may become involved after testing, when patients share results or need follow-up evaluation.
- Providers who receive results through their patients may use them to guide counseling, surveillance, or treatment decisions.
- No action is required from providers to order testing — Color’s internal clinician network reviews and approves all test requests submitted through the program.
Workflow
How to use this program
- 1
Discuss Program
Talk with eligible patients about the OCRA free genetic testing program and how at-home testing through Color Health may help clarify hereditary cancer risk. Share the link so they can apply directly.
- 2
Support Testing
Answer patient questions, encourage them to complete the Color Health questionnaire, and be available if they need help understanding whether the program fits their situation.
- 3
Review Results
If your patient feels comfortable sharing their results, use the findings to guide risk assessment, surveillance planning, and referrals for further evaluation or management as appropriate.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Color Health, a CLIA-certified laboratory (CLIA 05D2081492) and College of American Pathologists (CAP) certified laboratory (CAP 8975161). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
Which patients are appropriate for the OCRA sponsored hereditary cancer testing program?
The OCRA program is designed for individuals at increased risk for ovarian or gynecologic cancers, as well as those who may carry mutations associated with related hereditary cancer syndromes. Both male and female patients may be eligible, as the panel also evaluates inherited risk for breast, uterine/endometrial, colorectal, and prostate cancers. Patients must meet the program's eligibility criteria, which are defined on the program's application page.
What does the OCRA hereditary cancer panel test for beyond ovarian cancer genes?
The OCRA hereditary cancer testing program evaluates inherited risk not only for ovarian and gynecologic cancers but also for breast, uterine/endometrial, colorectal, and prostate cancers. Testing is performed by Color Health and is designed to support comprehensive risk assessment across multiple hereditary cancer syndromes.
What specimen is required and how is the OCRA genetic testing kit delivered?
The OCRA program uses an at-home saliva collection kit provided by Color Health. The kit is shipped directly to the patient after eligibility is confirmed. No phlebotomy or in-office specimen collection is required, which can streamline the testing process for both patient and practice.
Is genetic counseling included with the OCRA sponsored testing program?
Yes. The OCRA program includes access to certified genetic counselors at no cost to the patient or ordering clinician. Counselors are available to review results and support clinical decision-making, risk assessment, and cascade testing discussions with the patient and their care team.
Is there any cost or prescribing obligation when ordering through the OCRA hereditary cancer testing program?
There is no cost to the patient or the ordering clinician. AstraZeneca sponsors the program in full, covering testing and genetic counseling. Ordering through the OCRA program carries no purchase or prescribing obligation of any kind.
Is the OCRA sponsored genetic testing program available outside the United States?
The OCRA Free Genetic Testing Program is currently available to individuals in the United States only. Clinicians treating patients outside the US should explore alternative hereditary cancer testing options in their respective regions.
Which patients are eligible for Ovarian Cancer Ovarian Cancer genetic testing?
Patients may qualify for Ovarian Cancer if they meet the program's eligibility criteria:
- (Note: This program does not require an outside provider to initiate testing. Color’s clinical team handles authorization.)
- Providers may become involved after testing, when patients share results or need follow-up evaluation.
- Providers who receive results through their patients may use them to guide counseling, surveillance, or treatment decisions.
- No action is required from providers to order testing — Color’s internal clinician network reviews and approves all test requests submitted through the program.
See an issue with this program?